https://www.avient.com/sites/default/files/2022-04/Avient Q1 2022 Earnings Release.pdf
Three Months Ended March 31, 2022 Three Months Ended March 31, 2021 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income attributable to Avient shareholders $ 84.2 $ 0.91 $ 79.3 $ 0.86 Special items, after tax (Attachment 3) 7.2 0.08 2.6 0.03 Adjusted net income / EPS - excluding special items $ 91.4 $ 0.99 $ 81.9 $ 0.89 6 Attachment 2 Avient Corporation Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended March 31, 2022 2021 Sales $ 1,293.8 $ 1,162.3 Cost of sales 1,000.1 859.9 Gross margin 293.7 302.4 Selling and administrative expense 165.1 182.0 Operating income 128.6 120.4 Interest expense, net (16.9) (19.3) Other (expense) income, net (0.6) 1.5 Income before income taxes 111.1 102.6 Income taxes (26.6) (22.9) Net income 84.5 79.7 Net income attributable to noncontrolling interests (0.3) (0.4) Net income attributable to Avient shareholders $ 84.2 $ 79.3 Earnings per share attributable to Avient common shareholders - Basic $ 0.92 $ 0.87 Earnings per share attributable to Avient common shareholders - Diluted $ 0.91 $ 0.86 Cash dividends declared per share of common stock $ 0.2375 $ 0.2125 Weighted-average shares used to compute earnings per common share: Basic 91.5 91.3 Diluted 92.3 92.2 7 Attachment 3 Avient Corporation Summary of Special Items (Unaudited) (In millions, except per share data) Special items (1) Three Months Ended March 31, 2022 2021 Cost of sales: Restructuring costs, including accelerated depreciation and amortization $ (4.4) $ (1.8) Environmental remediation costs (2.0) (0.5) Reimbursement of previously incurred environmental costs 0.6 4.5 Impact on cost of sales (5.8) 2.2 Selling and administrative expense: Restructuring, legal and other 0.9 (1.3) Acquisition related costs (2.9) (3.3) Impact on selling and administrative expense (2.0) (4.6) Impact on operating income (7.8) (2.4) Other income, net 0.1 — Impact on income before income taxes (7.7) (2.4) Income tax benefit on above special items 2.0 0.9 Tax adjustments(2) (1.5) (1.1) Impact of special items on net income attributable to Avient Shareholders $ (7.2) $ (2.6) Diluted earnings per common share impact $ (0.08) $ (0.03) Weighted average shares used to compute adjusted earnings per share: Diluted 92.3 92.2 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to- market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results. (2) Tax adjustments include the net tax benefit/(expense) from one-time income tax items, the set-up or reversal of uncertain tax position reserves and deferred income tax valuation allowance adjustments. 8 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (In millions) (Unaudited) March 31, 2022 December 31, 2021 ASSETS Current assets: Cash and cash equivalents $ 562.6 $ 601.2 Accounts receivable, net 757.9 642.3 Inventories, net 475.4 461.1 Other current assets 131.0 122.4 Total current assets 1,926.9 1,827.0 Property, net 661.9 676.1 Goodwill 1,283.4 1,286.4 Intangible assets, net 904.1 925.2 Operating lease assets, net 67.1 74.1 Other non-current assets 200.3 208.4 Total assets $ 5,043.7 $ 4,997.2 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 607.5 $ 8.6 Accounts payable 642.3 553.9 Current operating lease obligations 21.7 24.2 Accrued expenses and other current liabilities 284.8 353.9 Total current liabilities 1,556.3 940.6 Non-current liabilities: Long-term debt 1,250.2 1,850.3 Pension and other post-retirement benefits 98.5 100.0 Deferred income taxes 99.4 100.6 Non-current operating lease obligations 45.9 50.1 Other non-current liabilities 164.1 165.1 Total non-current liabilities 1,658.1 2,266.1 SHAREHOLDERS' EQUITY Avient shareholders’ equity 1,813.2 1,774.7 Noncontrolling interest 16.1 15.8 Total equity 1,829.3 1,790.5 Total liabilities and equity $ 5,043.7 $ 4,997.2 9 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Three Months Ended March 31, 2022 2021 Operating Activities Net income $ 84.5 $ 79.7 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 35.7 36.6 Accelerated depreciation and amortization 2.1 0.5 Share-based compensation expense 3.2 2.7 Changes in assets and liabilities, net of the effect of acquisitions: Increase in accounts receivable (118.8) (137.6) Increase in inventories (15.1) (35.1) Increase in accounts payable 90.5 67.3 Decrease in pension and other post-retirement benefits (4.0) (7.1) Decrease in accrued expenses and other assets and liabilities, net (59.2) (3.4) Net cash provided by operating activities 18.9 3.6 Investing activities Capital expenditures (13.3) (16.5) Other investing activities — (2.0) Net cash used by investing activities (13.3) (18.5) Financing activities Purchase of common shares for treasury (15.8) (4.2) Cash dividends paid (21.7) (19.5) Repayment of long-term debt (2.4) (2.3) Payments of withholding tax on share awards (3.9) (3.1) Net cash used by financing activities (43.8) (29.1) Effect of exchange rate changes on cash (0.4) (11.0) Decrease in cash and cash equivalents (38.6) (55.0) Cash and cash equivalents at beginning of year 601.2 649.5 Cash and cash equivalents at end of period $ 562.6 $ 594.5 10 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.
https://www.avient.com/sites/default/files/resources/Innovation_Day_-_May_2014_0.pdf
Patterson President and Chief Executive Officer PolyOne Corporation Page 27 Well Positioned for Revenue Growth Addressable Market by Platform $540 $215 $120 $40 $260 $525 ($ millions) Design/Service Sustainable Solutions Surface Modification Lightweighting Thermal Control Flame Retardancy $1.0 - $2.0 Billion of revenue generated from new products in 5 years Gross margin on new products exceed current gross margin by at least 10 percentage points World class vitality index of ≥ 35% 2018 PolyOne Corporation Page 28 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 29 2006 2013 Revenue ($ millions) Health and Wellness Evolution General purpose tubing TPE applications from GLS Specialty tubing Ergonomic enhancements Pre-certified biocompatible colorants Highly sophisticated catheter and drug delivery components Chemical and heat sterilizable materials Authentication and protection technologies Addressing wellness, prevention, diagnostic and therapy changes in healthcare setting Healthcare packaging solutions 2006 2015 & Beyond $416 $105 PolyOne Corporation Page 30 Transportation Evolution General purpose formulations (bumpers, roof racks) Long fiber for lightweighting Thermal management for LED lighting Thermoset composite pultrusions Conductive polymers for EMI shielding Formulations for aerospace interiors Thermoplastic composites High temperature formulations for aerospace Expand 3D printing capabilities 2006 2015 & Beyond 2006 2013 Revenue ($ millions) $709 $315 PolyOne Corporation Page 31 Packaging Evolution Masterbatch colors and PVC packaging materials TPEs to enhance brand appeal and consumer functionality Liquid color and additive technologies to extend shelf life, preserve taste and differentiate brands Leveraging color, additives and sheet technology for healthcare and consumer packaging solutions 2006 2015 & Beyond 2006 2013 Revenue ($ millions) $612 $260 PolyOne Corporation Page 32 Consumer Evolution Commodity plastic and masterbatch color solutions Engineered materials to enhance customer appeal through visual and performance improvements Formulated metal- to-polymer conversion to enhance performance and reduce manufacturing costs Biopolymers & composite materials leveraging unique color technology to build brand identity 2006 2015 & Beyond 2006 2013 Revenue ($ millions) $394 $228 PolyOne Corporation Page 33 Interactive Display Introduction PolyOne Corporation Page 34 Interactive Displays INNOVATION DISCUSSION LEADER TECHNOLOGIES MARKETS Polycast™ Bullet Resistant Sheet Aerospace GlasArmor™ Ballistic Resistant Panels Security reFlex™ Bio-Based Plasticizer Solutions Wilflex™ Oasis Hydrate InVisiO℠ Color Inspiration Forecast In-Store Audits OnColor™ Portfolio Light Weighting Thermal Management Corrosion Resistance Design Flexibility Sustainability Global Supply Chain Ergonomics and Aesthetics Consumer Appeal 9) Consumer Electronics Solutions Walter Ripple General Manager GLS Personal Electronics Wearable Electronics Hand Held Devices Portable Audio 7) Metal Replacement Technology Kurt Schuering Vice President Global Key Account Management Aerospace Transportation Electrical & Electronics Sporting and Shooting 8) Medical Device Solutions Dr.
https://www.avient.com/sites/default/files/2021-05/renol-ul94-compliant-masterbatches-brochure.pdf
In order to have a masterbatch recognized by UL, the following conditions must be met: • the color concentrate producer must be recognized by UL • the polymer, generic or specific, must be recognized as well • the recognition of the material combination (base resin + color concentrate) must be listed in the QMSQ2 file of the concentrate producer • the specification limits set in the QMQS2 file must be respected if the UL94 recognition is to apply to the final plastic part Avient has a wide range of color and cost options available to provide maximum flexibility.